Background Increasing evidence supports a link between myocardial fibrosis (MF) and
ventricular arrhythmias. Objectives The purpose of this study was to determine whether …

Objectives: The purpose of this study was to evaluate the association between regional
myocardial fibrosis and ventricular arrhythmias in patients with cardiomyopathy …

Ventricular Fibrosis in Patients With NICM Background Current guidelines recommend the
implantation of an implantable cardioverter‐defibrillator (ICD) for primary prevention of …

Background The “gray zone” of myocardial fibrosis (GZF) on cardiovascular magnetic
resonance may be a substrate for ventricular arrhythmias (VAs). Objectives The purpose of …

Objectives: The authors performed a meta-analysis to evaluate the predictive value of late
gadolinium enhancement (LGE) cardiac magnetic resonance for ventricular tachyarrhythmia …

Myocardial fibrosis is a common pattern in the setting of different heart diseases, and
promotes ventricular tachyarrhythmias by creating a vulnerable substrate for reentrant …

Objectives: The goal of this study was to explore whether fibrosis detected by late
gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is an independent …

Background Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated
cardiomyopathy (NIDC) relies on left ventricular (LV) dysfunction, a poor marker of …

Aims To determine whether myocardial fibrosis and greyzone fibrosis (GZF) on
cardiovascular magnetic resonance (CMR) is associated with ventricular arrhythmias in …

Background Diffuse myocardial fibrosis may provide a substrate for the initiation and
maintenance of ventricular arrhythmia. T1 mapping overcomes the limitations of the …